Cargando…
The long‐term evolution of melanocytic nevi among high‐risk adults
BACKGROUND: There is little understanding regarding the long‐term natural history of melanocytic nevi among adults. OBJECTIVE: The objective of the study was to describe the long‐term natural history of individual nevi located on the torso of high‐risk patients. METHODS: All patients attending Memor...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804380/ https://www.ncbi.nlm.nih.gov/pubmed/35881111 http://dx.doi.org/10.1111/jdv.18470 |
_version_ | 1784862095077015552 |
---|---|
author | Reiter, O. Kurtansky, N.R. Musthaq, S.T. Dusza, S. Halpern, A.C. Marchetti, M.A. Marghoob, A.A. Scope, A. Rotemberg, V. |
author_facet | Reiter, O. Kurtansky, N.R. Musthaq, S.T. Dusza, S. Halpern, A.C. Marchetti, M.A. Marghoob, A.A. Scope, A. Rotemberg, V. |
author_sort | Reiter, O. |
collection | PubMed |
description | BACKGROUND: There is little understanding regarding the long‐term natural history of melanocytic nevi among adults. OBJECTIVE: The objective of the study was to describe the long‐term natural history of individual nevi located on the torso of high‐risk patients. METHODS: All patients attending Memorial Sloan Kettering Cancer Center (MSKCC) who underwent two total body photography (TBP) sessions 15+ years apart were included (‘retrospective’ group). To account for a potential selection bias, we also included consecutive patients who had TBP 15+ years ago and consented to undergo follow‐up TBP (‘prospective’ group). We compared baseline and follow‐up torso images on the TBPs and evaluated the number of total, new and disappearing nevi; number of seborrheic keratoses and actinic keratoses; each nevus' diameter at both time points; each nevus' colour change; the presence of clinical atypia; and when dermoscopy was available, the dermoscopic features at each time point. RESULTS: One hundred six patients were included in the study. Although the average age of the patients was 40 at baseline TBP, most patients developed new nevi between imaging sessions (median 16.4 years) with an average of 2.6 (SD = 4.8) nevi per participant. The average number of disappearing nevi was 0.3 (SD = 0.6). In addition, 62/106 (58%) patients had an absolute increase, and 9/106 (8%) patients had an absolute decrease in their total nevus count. Roughly half (49%: 1416/2890) of the nevi that could be evaluated at both time points increased in diameter by at least 25%. Only 6% (159/2890) of nevi shrunk in diameter by at least 25%. Patients with a history of melanoma had a higher rate of disappearing nevi, and their nevi were more likely to grow. Most nevi demonstrated no significant dermoscopic changes. CONCLUSIONS: High‐risk patients acquire new nevi throughout life with very few nevi disappearing over time. Contrary to prior reports, most nevi in adults increase in diameter, while few nevi shrink. |
format | Online Article Text |
id | pubmed-9804380 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-98043802023-01-03 The long‐term evolution of melanocytic nevi among high‐risk adults Reiter, O. Kurtansky, N.R. Musthaq, S.T. Dusza, S. Halpern, A.C. Marchetti, M.A. Marghoob, A.A. Scope, A. Rotemberg, V. J Eur Acad Dermatol Venereol Original Articles and Short Reports BACKGROUND: There is little understanding regarding the long‐term natural history of melanocytic nevi among adults. OBJECTIVE: The objective of the study was to describe the long‐term natural history of individual nevi located on the torso of high‐risk patients. METHODS: All patients attending Memorial Sloan Kettering Cancer Center (MSKCC) who underwent two total body photography (TBP) sessions 15+ years apart were included (‘retrospective’ group). To account for a potential selection bias, we also included consecutive patients who had TBP 15+ years ago and consented to undergo follow‐up TBP (‘prospective’ group). We compared baseline and follow‐up torso images on the TBPs and evaluated the number of total, new and disappearing nevi; number of seborrheic keratoses and actinic keratoses; each nevus' diameter at both time points; each nevus' colour change; the presence of clinical atypia; and when dermoscopy was available, the dermoscopic features at each time point. RESULTS: One hundred six patients were included in the study. Although the average age of the patients was 40 at baseline TBP, most patients developed new nevi between imaging sessions (median 16.4 years) with an average of 2.6 (SD = 4.8) nevi per participant. The average number of disappearing nevi was 0.3 (SD = 0.6). In addition, 62/106 (58%) patients had an absolute increase, and 9/106 (8%) patients had an absolute decrease in their total nevus count. Roughly half (49%: 1416/2890) of the nevi that could be evaluated at both time points increased in diameter by at least 25%. Only 6% (159/2890) of nevi shrunk in diameter by at least 25%. Patients with a history of melanoma had a higher rate of disappearing nevi, and their nevi were more likely to grow. Most nevi demonstrated no significant dermoscopic changes. CONCLUSIONS: High‐risk patients acquire new nevi throughout life with very few nevi disappearing over time. Contrary to prior reports, most nevi in adults increase in diameter, while few nevi shrink. John Wiley and Sons Inc. 2022-08-05 2022-12 /pmc/articles/PMC9804380/ /pubmed/35881111 http://dx.doi.org/10.1111/jdv.18470 Text en © 2022 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Articles and Short Reports Reiter, O. Kurtansky, N.R. Musthaq, S.T. Dusza, S. Halpern, A.C. Marchetti, M.A. Marghoob, A.A. Scope, A. Rotemberg, V. The long‐term evolution of melanocytic nevi among high‐risk adults |
title | The long‐term evolution of melanocytic nevi among high‐risk adults |
title_full | The long‐term evolution of melanocytic nevi among high‐risk adults |
title_fullStr | The long‐term evolution of melanocytic nevi among high‐risk adults |
title_full_unstemmed | The long‐term evolution of melanocytic nevi among high‐risk adults |
title_short | The long‐term evolution of melanocytic nevi among high‐risk adults |
title_sort | long‐term evolution of melanocytic nevi among high‐risk adults |
topic | Original Articles and Short Reports |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804380/ https://www.ncbi.nlm.nih.gov/pubmed/35881111 http://dx.doi.org/10.1111/jdv.18470 |
work_keys_str_mv | AT reitero thelongtermevolutionofmelanocyticneviamonghighriskadults AT kurtanskynr thelongtermevolutionofmelanocyticneviamonghighriskadults AT musthaqst thelongtermevolutionofmelanocyticneviamonghighriskadults AT duszas thelongtermevolutionofmelanocyticneviamonghighriskadults AT halpernac thelongtermevolutionofmelanocyticneviamonghighriskadults AT marchettima thelongtermevolutionofmelanocyticneviamonghighriskadults AT marghoobaa thelongtermevolutionofmelanocyticneviamonghighriskadults AT scopea thelongtermevolutionofmelanocyticneviamonghighriskadults AT rotembergv thelongtermevolutionofmelanocyticneviamonghighriskadults AT reitero longtermevolutionofmelanocyticneviamonghighriskadults AT kurtanskynr longtermevolutionofmelanocyticneviamonghighriskadults AT musthaqst longtermevolutionofmelanocyticneviamonghighriskadults AT duszas longtermevolutionofmelanocyticneviamonghighriskadults AT halpernac longtermevolutionofmelanocyticneviamonghighriskadults AT marchettima longtermevolutionofmelanocyticneviamonghighriskadults AT marghoobaa longtermevolutionofmelanocyticneviamonghighriskadults AT scopea longtermevolutionofmelanocyticneviamonghighriskadults AT rotembergv longtermevolutionofmelanocyticneviamonghighriskadults |